Search
Artivion Inc
AORTAdd to Watchlist
27.015USD
+0.915+3.51%
Close 07-28 16:00（ET）Quotes delayed by 15 min
1.31BMarket Cap
105.28P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-28The current earnings forecast score of Artivion Inc is 8.75, ranking 16 out of 199 in the Healthcare Equipment & Supplies industry. The average price target is 53.00, with a high of 58.00 and a low of 40.00.
Analyst Rating
Based on
8
analysts
Buy
Current Rating
42.000
Target Price
+66.14%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
109
Total
7
Median
9
Average
Company name
Ratings
Analysts
Artivion Inc
AORT
8
Medtronic PLC
MDT
34
Stryker Corp
SYK
32
Dexcom Inc
DXCM
32
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
29
1
2
3
...
22
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Artivion Inc's expected revenue for the next quarter?
Artivion Inc's expected revenue is 120.01M.
What is Artivion Inc's price target?
Analysts forecast that Artivion Inc's price target is USD 53.00, with the highest forecast at USD 58.00 and the lowest forecast at USD 40.00.
How have Artivion IncAORT's recent earnings per share performed?
The market expectation was USD 0.03, while Artivion IncAORT's earnings per share (EPS) for the previous quarter was USD 0.05. EPS for the next quarter is expected at USD 0.01.
What is the analyst rating for Artivion Inc?
Based on the ratings of Artivion Inc's stock from 8 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.